Stockscreener 앱 받기
11.62
9.64%
-1.24
전일 마감가:
$12.86
열려 있는:
$12.7
하루 거래량:
7.18M
Relative Volume:
4.36
시가총액:
$1.15B
수익:
-
순이익/손실:
$-44.84M
주가수익비율:
-24.72
EPS:
-0.47
순현금흐름:
$-44.23M
1주 성능:
-13.93%
1개월 성능:
-34.54%
6개월 성능:
+13.92%
1년 성능:
-10.48%
1일 변동 폭
$10.98
$12.70
1주일 범위
$10.98
$14.00
52주 변동 폭
$10.01
$18.90
Ars Pharmaceuticals Inc Stock (SPRY) Company Profile
명칭
Ars Pharmaceuticals Inc
전화
858-771-9307
주소
11682 EL CAMINO REAL, SUITE 120, SAN DIEGO
SPRY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SPRY
Ars Pharmaceuticals Inc
|
11.62 | 1.27B | 0 | -44.84M | -44.23M | -0.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Ars Pharmaceuticals Inc Stock (SPRY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2025-02-10 | 개시 | Oppenheimer | Outperform |
| 2024-08-20 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-13 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-08-12 | 재확인 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | Raymond James | Outperform |
| 2024-03-05 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-02-20 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2023-09-20 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | 개시 | Wedbush | Outperform |
| 2023-01-03 | 개시 | William Blair | Outperform |
| 2022-12-13 | 개시 | SVB Leerink | Outperform |
모두보기
Ars Pharmaceuticals Inc 주식(SPRY)의 최신 뉴스
Risk vs reward if holding onto ARS Pharmaceuticals Inc.Portfolio Growth Summary & Real-Time Sentiment Analysis - Newser
Does ARS Pharmaceuticals Inc. have strong fundamentalsJobs Report & Advanced Technical Analysis Signals - خودرو بانک
Comparing ARS Pharmaceuticals Inc. in custom built stock radarsInsider Buying & Long Hold Capital Preservation Plans - Newser
What recovery options are there for ARS Pharmaceuticals Inc.July 2025 Review & Safe Capital Investment Plans - Newser
ARS Pharmaceuticals Inc. recovery potential after sell off2025 Market Sentiment & Smart Investment Allocation Tips - Newser
ARS Pharmaceuticals Inc. At Decision Level — Rebound or Resistance2025 Performance Recap & Long-Term Growth Plans - beatles.ru
Using data models to predict ARS Pharmaceuticals Inc. stock movement2025 Stock Rankings & Weekly Breakout Stock Alerts - Newser
Quantitative breakdown of ARS Pharmaceuticals Inc. recent moveJuly 2025 Action & Pattern Based Trade Signal System - Newser
Real time social sentiment graph for ARS Pharmaceuticals Inc.Insider Selling & Expert-Curated Trade Recommendations - Newser
Ars Pharmaceuticals Reports Strong Q2 Growth and Global Expansion - TipRanks
Is ARS Pharmaceuticals Inc. forming a bottoming base2025 Market Overview & Fast Gain Swing Alerts - Newser
How to monitor ARS Pharmaceuticals Inc. with trend dashboardsQuarterly Profit Report & Free Technical Confirmation Trade Alerts - Newser
Analyzing ARS Pharmaceuticals Inc. with multi timeframe charts2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - Newser
Analyzing net buyer seller activity in ARS Pharmaceuticals Inc.2025 Key Highlights & Risk Controlled Stock Alerts - Newser
What machine learning models say about ARS Pharmaceuticals Inc.2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - Newser
Can ARS Pharmaceuticals Inc. rally from current levels2025 Year in Review & Expert Verified Movement Alerts - Newser
How to interpret RSI for ARS Pharmaceuticals Inc. stockWeekly Risk Report & AI Powered Market Entry Strategies - Newser
Custom watchlist performance reports with ARS Pharmaceuticals Inc.2025 Major Catalysts & Fast Exit and Entry Strategy Plans - Newser
What MACD and RSI say about ARS Pharmaceuticals Inc.July 2025 Analyst Calls & Safe Capital Allocation Plans - Newser
Ranking ARS Pharmaceuticals Inc. among high performing stocks via toolsQuarterly Growth Report & Free Reliable Trade Execution Plans - Newser
Technical analysis overview for ARS Pharmaceuticals Inc. stock - Newser
Real time pattern detection on ARS Pharmaceuticals Inc. stockIPO Watch & Weekly Chart Analysis and Trade Guides - Newser
ARS Pharma drops 9% as Lupin files application for generic neffy - MSN
What machine learning models say about ARS Pharmaceuticals Inc2025 Performance Recap & AI Powered Buy and Sell Recommendations - Newser
How hedge fund analytics apply to ARS Pharmaceuticals Inc. stockSwing Trade & Proven Capital Preservation Tips - Newser
How high can ARS Pharmaceuticals Inc. stock goSell Signal & Daily Volume Surge Trade Alerts - Newser
Advanced analytics toolkit walkthrough for ARS Pharmaceuticals Inc.2025 Analyst Calls & AI Driven Price Predictions - Newser
Price momentum metrics for ARS Pharmaceuticals Inc. explained2025 Support & Resistance & High Yield Stock Recommendations - Newser
Custom watchlist performance reports with ARS Pharmaceuticals IncProfit Target & Daily Technical Forecast Reports - Newser
ARS Pharmaceuticals Faces Wider Loss in Q2, Stirring Market Concerns - StocksToTrade
Trading Bots Trigger Alerts on ARS Pharmaceuticals Inc. Activity getLinesFromResByArray error: size == 0 - thegnnews.com
ARS Pharmaceuticals Down 9% as Lupin Files Generic Neffy Application - AInvest
What the charts say about ARS Pharmaceuticals Inc. today2025 Biggest Moves & AI Driven Stock Reports - Newser
Ars Pharmaceuticals Inc (SPRY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.96%
1.09%
자본화:
|
볼륨(24시간):